GB0520743D0 - Compounds and their use - Google Patents
Compounds and their useInfo
- Publication number
- GB0520743D0 GB0520743D0 GBGB0520743.6A GB0520743A GB0520743D0 GB 0520743 D0 GB0520743 D0 GB 0520743D0 GB 0520743 A GB0520743 A GB 0520743A GB 0520743 D0 GB0520743 D0 GB 0520743D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0520743.6A GB0520743D0 (en) | 2005-10-12 | 2005-10-12 | Compounds and their use |
PCT/GB2006/003791 WO2007042815A1 (en) | 2005-10-12 | 2006-10-12 | Compounds containing more than one human neutrophil elastase inhibiting moiety for use in the treatment of respiratory diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0520743.6A GB0520743D0 (en) | 2005-10-12 | 2005-10-12 | Compounds and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0520743D0 true GB0520743D0 (en) | 2005-11-23 |
Family
ID=35451608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0520743.6A Ceased GB0520743D0 (en) | 2005-10-12 | 2005-10-12 | Compounds and their use |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0520743D0 (en) |
WO (1) | WO2007042815A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009013444A1 (en) * | 2007-07-25 | 2009-01-29 | Argenta Discovery Limited | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
ATE480543T1 (en) | 2006-05-04 | 2010-09-15 | Pulmagen Therapeutics Inflamma | TETRAHYDROPYRROLOPYRIMIDIINDIONE AND THEIR USE AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE |
US8198288B2 (en) | 2006-05-04 | 2012-06-12 | Pulmagen Therapeutics (Inflammation) Limited | Tetrahydropyrrolopyrimidinediones and their use in therapy |
GB0721866D0 (en) * | 2007-11-07 | 2007-12-19 | Argenta Discovery Ltd | Pharmaceutical compounds having dual activities |
DE102008052013A1 (en) | 2008-10-17 | 2010-04-22 | Bayer Schering Pharma Aktiengesellschaft | New 4-(4-cyano-2-thioaryl)dihydropyrimidinone compounds are neutrophil elastase inhibitors useful to treat or prevent e.g. pulmonary arterial hypertension, chronic obstructive pulmonary disease, acute lung injury, or cystic fibrosis |
SG10201604819TA (en) | 2007-12-20 | 2016-07-28 | Bayer Ip Gmbh | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
DE102008022521A1 (en) | 2008-05-07 | 2009-11-12 | Bayer Schering Pharma Aktiengesellschaft | 1,4-Diaryl-pyrimidopyridazine-2,5-diones and their use |
DE102007061766A1 (en) | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
DE102009016553A1 (en) | 2009-04-06 | 2010-10-07 | Bayer Schering Pharma Aktiengesellschaft | Sulfonamide- and sulfoximine-substituted diaryldihydropyrimidinones and their use |
GB201004179D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
GB201004178D0 (en) * | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
DE102010030187A1 (en) | 2010-06-16 | 2011-12-22 | Bayer Schering Pharma Aktiengesellschaft | New 4-cyano-2-sulfonylphenyl-pyrazolyl-substituted pyridinones and pyrazinones compounds are human neutrophil elastase inhibitors, useful to treat and prevent e.g. pulmonary arterial hypertension and chronic obstructive pulmonary disease |
KR20170129191A (en) | 2015-03-18 | 2017-11-24 | 바이엘 파마 악티엔게젤샤프트 | (4S) -4- [4-Cyano-2- (methylsulfonyl) phenyl] -3,6- dimethyl-2-oxo-1- [3- (trifluoromethyl) , 3,4-tetrahydropyrimidine-5-carbonitrile |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003255492A1 (en) * | 2002-09-10 | 2004-04-30 | Bayer Healthcare Ag | Heterocyclic derivatives |
GB0502258D0 (en) * | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
-
2005
- 2005-10-12 GB GBGB0520743.6A patent/GB0520743D0/en not_active Ceased
-
2006
- 2006-10-12 WO PCT/GB2006/003791 patent/WO2007042815A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007042815A1 (en) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0512940D0 (en) | Compounds and their use | |
GB0520743D0 (en) | Compounds and their use | |
IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
EP1912921A4 (en) | Tetraazaporphyrin-based compounds and their uses | |
EP1921066A4 (en) | Pyridylphenol compound and use thereof | |
GB0520176D0 (en) | Use | |
GB0511190D0 (en) | Use | |
IL185223A0 (en) | Compounds and uses thereof | |
GB0502250D0 (en) | Use | |
GB0526032D0 (en) | Use | |
GB0526031D0 (en) | Use | |
GB0521278D0 (en) | Compounds and their use | |
GB0513176D0 (en) | Compounds and their use | |
GB0427723D0 (en) | Compounds and their use | |
GB0522867D0 (en) | Compounds and their uses | |
GB0515913D0 (en) | Compounds and their uses | |
GB0515688D0 (en) | Compounds and their uses | |
GB0514471D0 (en) | Compounds and their uses | |
GB0510067D0 (en) | Compounds and their uses | |
GB0506545D0 (en) | Compounds and their uses | |
GB0525328D0 (en) | Compounds and their uses | |
GB0510263D0 (en) | Compounds and their uses | |
ZA200804378B (en) | Iminopropene compound and use thereof | |
GB0514416D0 (en) | Compounds and uses thereof | |
GB0521272D0 (en) | Compounds and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |